Vis enkel innførsel

Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January–June 2020)

dc.contributor.authorAl-Qahtani, Mohammed
dc.contributor.authorBehe, Martin
dc.contributor.authorBormans, Guy
dc.contributor.authorCarlucci, Giuseppe
dc.contributor.authorDasilva, Jean
dc.contributor.authorDecristoforo, Clemens
dc.contributor.authorElsinga, Philip H
dc.contributor.authorKopka, Klaus
dc.contributor.authorLi, Xiang-Guo
dc.contributor.authorMach, Robert L.
dc.contributor.authorMiddel, Oskar
dc.contributor.authorPasschier, Jan
dc.contributor.authorPatt, Marianne
dc.contributor.authorPenuelas, Ivan
dc.contributor.authorRey, Ana
dc.contributor.authorScott, Peter
dc.contributor.authorTodde, Sergio
dc.contributor.authorToyohara, Jun
dc.contributor.authorVugts, Danielle
dc.date.accessioned2021-03-17T07:29:00Z
dc.date.available2021-03-17T07:29:00Z
dc.date.created2021-03-16T12:50:44Z
dc.date.issued2021
dc.identifier.citationEJNMMI Radiopharmacy and Chemistry. 2021, 6, .en_US
dc.identifier.issn2365-421X
dc.identifier.urihttps://hdl.handle.net/11250/2733792
dc.description.abstractBackground: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to describe trends in the field. Results: This commentary of highlights has resulted in 19 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.en_US
dc.language.isoengen_US
dc.publisherSpringer Natureen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleHighlight selection of radiochemistry and radiopharmacy developments by editorial board (January–June 2020)en_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.volume6en_US
dc.source.journalEJNMMI Radiopharmacy and Chemistryen_US
dc.identifier.doi10.1186/s41181-020-00118-5
dc.identifier.cristin1898328
dc.description.localcodeThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.en_US
dc.source.articlenumber5en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail
Filnavn:
Middels_Oskar_41181_2020_Artic ...
Størrelse:
1.591Mb
Format:
PDF
Beskrivelse:
Al-Qahtani
Åpne

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal